SLNSW-Targeted-release budesonide versus placebo in pat...-TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

Full title: Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

Author/creator: NEFIGAN Trial Investigators, Fellström, Bengt C, Prof, Barratt, Jonathan, FRCP, Cook, Heather, PhD, Coppo, Rosanna, MD, Feehally, John, Prof, de Fijter, Johan W, Prof, Floege, Jürgen, Prof, Hetzel, Gerd, Prof, Jardine, Alan G, Prof, Locatelli, Francesco, FRCP, Maes, Bart D, Prof, Mercer, Alex, PhD, Ortiz, Fernanda, PhD, Praga, Manuel, Prof, Sørensen, Søren S, Prof, Tesar, Vladimir, Prof, Del Vecchio, Lucia, MD.

Call Numbers:

Record Identifier: TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

    Record identifier

    TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

    Share

    Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

    Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

    Full title

    Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

    Author / Creator

    NEFIGAN Trial Investigators ; Fellström, Bengt C, Prof ; Barratt, Jonathan, FRCP ; Cook, Heather, PhD ; Coppo, Rosanna, MD ; Feehally, John, Prof ; de Fijter, Johan W, Prof ; Floege, Jürgen, Prof ; Hetzel, Gerd, Prof ; Jardine, Alan G, Prof ; Locatelli, Francesco, FRCP ; Maes, Bart D, Prof ; Mercer, Alex, PhD ; Ortiz, Fernanda, PhD ; Praga, Manuel, Prof ; Sørensen, Søren S, Prof ; Tesar, Vladimir, Prof ; Del Vecchio, Lucia, MD

    Publisher

    England: Elsevier Ltd

    Journal title

    The Lancet (British edition), 2017, Vol.389 (10084), p.2117-2127

    Record Identifier

    TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Adults Albumin Algorithms Analysis Angiotensin Antibodies Antigen-antibody complexes Appendix Attenuation Biocompatibility Biopsy Budesonide Budesonide - administration & dosage Care and treatment Cell activation Cell proliferation Chronic kidney failure Circulation Clinical Medicine Clinical trials Collection Committees Complications Constrictions Corticoids Corticosteroids Creatinine Diabetes mellitus Diagnosis Diet Dose-Response Relationship, Drug Double-Blind Method Drug delivery Drug Delivery Systems Drug dosages Drug therapy Drugs End-stage renal disease Enzyme inhibitors Evidence-based medicine Excretion Female Filtration Gastrointestinal tract Glomerular Filtration Rate Glomerulonephritis Glomerulonephritis, IGA - drug therapy Glomerulonephritis, IGA - pathology Glucocorticoids - administration & dosage Health risks Humans Hypertension IgA nephropathy Ileum Immune system Immunoglobulin A Immunoglobulin G Immunoglobulins Immunosuppression Inflammation Inhibitors Internal Medicine Intestine Kidney diseases Kidney transplantation Kidneys Klinisk medicin Lymphocytes Lymphocytes B Male Medical and Health Sciences Medical treatment Medicin och hälsovetenskap Metabolism Middle Aged Mucosal immunity Nephritis Nephrology Optimization Osteoporosis Pathogenesis Peptidyl-dipeptidase A Pharmacokinetics Pharmacology Proteins Proteinuria Randomization Reduction Renal function Renin Risk factors Risk management Safety Steroids Stimulation Thromboembolism Thrombosis Titration Treatment Outcome Urine Urologi och njurmedicin Urology and Nephrology

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_325692

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    About resource >

    View in old catalogue

    Connecting people and collections